Although analysis from ccRCC tumor lysates revealed that increased AMPK mRNA and pAMPK are associated with favorable outcomes [1,6], the prognostic significance of pAMPK subcellular location has not yet been investigated in patients with ccRCC. Here, PRKAA2 is linked to nonpapillary renal cell carcinoma.